Galectin Therapeutics (GALT) Q1 2025 Annual Earnings
GALT·Reported May 15, 2025·Before market open
Diluted EPS came in at $-0.15 (+21.1% YoY), beat the $-0.20 consensus by $0.05.
Diluted EPS
$-0.15beat by $0.05
Consensus: $-0.20
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Galectin Therapeutics's Q1 2025 earnings report.
Galectin Therapeutics (GALT) reported Q1 2025 earnings on May 15, 2025 before market open.
Galectin Therapeutics reported diluted EPS of $-0.15 for Q1 2025.
EPS beat the consensus estimate of $-0.20 by $0.05.
Compared to the same quarter a year prior, diluted EPS grew 21.1% from $-0.19.
You can read the 10-K periodic report (0001140361-25-011169) directly on SEC EDGAR. The filing index links above go to sec.gov.